AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
EPOETIN ALFA
6 registrations across 3 African markets— 6 active
Markets with EPOETIN ALFA
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| BINOCRIT 4000IU/0.4ML SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE (EPOETIN ALFA) | 🇬🇭Ghana | — | active | Jan 2030 |
| EPREX 40 000/ml | 🇿🇦South Africa | Janssen Pharmaceutica (Pty) Ltd | active | Jan 1900 |
| EPREX 6 000 IU/0,6 ML | 🇿🇦South Africa | Janssen Pharmaceutica (Pty) Ltd | active | Jan 1900 |
| Erykine Injection | 🇹🇿Tanzania | Intas Pharmaceuticals Ltd | active | — |
| EPOSINO 2000 IU Injection Solution for injection/concentrate for solution for infusion | 🇹🇿Tanzania | MORAF PHARMACEUTICALS LTD | active | — |
| EPOSINO 4000 IU Injection Solution for injection/concentrate for solution for infusion | 🇹🇿Tanzania | MORAF PHARMACEUTICALS LTD | active | — |
EPOETIN ALFA in Africa — Regulatory Overview
EPOETIN ALFA is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, South Africa, Ghana. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 6 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.